Varricchi G, Poto R, Lommatzsch M, Brusselle G, Braido F, Virchow JC, Canonica GW. Allergy. 2024 Nov 9. doi: 10.1111/all.16382. Abstract Although airway remodeling in severe and/or fatal asthma is…
Pulm Pharmacol Ther. 2024 Nov 19:102333. doi: 10.1016/j.pupt.2024.102333. Highlights Abstract Long-acting muscarinic antagonists (LAMA) in association with inhaled corticosteroids (ICS) plus long-acting beta-2 agonists (LABA) are recommended by the GINA…
Deniz, S., Kuranoğlu, N. BMC Pulm Med 24, 586 (2024). https://doi.org/10.1186/s12890-024-03408-9 Abstract Background Obesity can lead to increased airway resistance, especially in the peripheral airways. Impulse oscillometry (IOS) may detect small…
Environmental Research. Available online 23 November 2024, 120445. In Press, Journal Pre-proof Highlights Abstract Background Asthma and allergic diseases are among the common causes of morbidity and mortality globally. Various…
Bagnasco D , Ansotegui I , Baiardini I et al. Pulmonary Pharmacology & TherapeuticsAvailable online 19 November 2024, 102333 In Press, Journal Pre-proof Highlights Abstract Long-acting muscarinic antagonists (LAMA) in…
Fan, R., Qian, H., Xu, JY. et al. Respir Res 25, 413 (2024). https://doi.org/10.1186/s12931-024-03034-3 Abstract Background Previous studies have demonstrated that asthma is closely associated with bronchiectasis, however, the causal relationship between asthma…
Goal is to inform the design of microbiome-based therapeutics that can help deliver antibiotics safely during early life and reduce the burden of childhood asthma. By: Jessica Pasley The use…
The GINA 2024 Diagnosis and Management of Difficult-to-treat & Severe Asthma Guide is now available to download. 2024 GINA Difficult-to-treat & Severe Asthma Guide The GINA 2024 Summary Guide, (formerly…
Wongsa, Chamard et al. Journal of Allergy and Clinical Immunology: Global, Volume 0, Issue 0, 100366 Abstract Background Inhaled corticosteroid (ICS) containing regimens are the mainstay for treating asthma despite…